The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
22 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The Translational Genomics Research Institute (TGen), formerly known as Arizona Bioscience and Bio-medicine Institute, is a non-profit organization that focuses on developing earlier diagnostics and treatments. The organization conducts clinical trials to investigate new chemical agents for the treatment of pancreatic cancer, breast cancer, leukemia, prostate cancer, lung cancer, and melanoma and incorporate novel tools for identifying patients' genomic characteristics for a more targeted approach. TGen employs advances from the human genome project to develop prognostics, diagnostics, and therapies for treatment of neurological disorders, cancer, diabetes and other complex diseases.

The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand t

  
Source:
Document ID
GDPH141961D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
The Translational Genomics Research Institute, Medical Devices Deals, 2010 to YTD 201691
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
The Translational Genomics Research Institute, Pharmaceuticals &Healthcare, Deal Details119
  Partnerships111
    TGen Enters into Research Agreement with Baylor Research Institute111
    BIO5 Oro Valley Enters Into Co-Development Agreement With TGen For Alzheimer s Disease121
    Virginia G. Piper Cancer Center And TGen Enter Into Co-Development Agreement With Samuel Oschin Comprehensive Cancer Institute131
    Life Technologies Enters Into Joint Venture With Fox Chase, Scripps Health And Translational Genomics Research Institute142
    Asuragen Enters Into An Agreement With The Translational Genomics Research Institute161
    Translational Genomics Research Institute Enters Into Agreement With Van Andel Research Institute171
    Geisinger Health Enters Into Research Agreement With The Translational Genomics181
  Licensing Agreements191
    Oncoholdings Receives License For ONCO-101 From The Translational Genomics Research Institute191
Key Employees201
Locations And Subsidiaries211
  Head Office211
  Other Locations &Subsidiaries211
Appendix221
  Methodology221
  About GlobalData221
  Contact Us221
  Disclaimer221

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Translational-Genomics-Research-Institute-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7728>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Translational-Genomics-Research-Institute-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7728>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research